Polynovo | PNV - 税前利润

股票价格
1.03
每天变化
-0.03 -2.37%
每月一次
7.85%
每年
-6.36%
Q2 预测
0.95


金融业
股票价格
AUD
资产
AUD 123.37M
现金及等价物
AUD 29.21M
销售成本
AUD 9.02M
流动资产
AUD 69.23M
流动负债
AUD 22.81M
债务
AUD 15.38M
EBIT
AUD 2.06M
EBITDA
AUD 3.89M
员工
301
EPS每股收益
AUD 0.01
股本和储备
AUD 83.14M
销售毛利
AUD 61.26M
债务利息支出
AUD 506K
贷款资金
AUD 15.39M
市值
AUD 728.2M
净收入
AUD 3K
营业费用
AUD 68.22M
营业利润
AUD 2.06M
普通股股本
AUD 690.84M
PE价格收益
58.54
税前利润
AUD 1.96M
销售收入
AUD 70.33M
销售和管理费用
AUD 17.05M
股票
AUD 8.97M
贸易债权人
AUD 4.9M
应收帐款人
AUD 24.21M


税前利润 更改 日
Ansell USD 33.35M 74.15M 2025-06
Avita Medical AUD -11.64M 12.13M 2025-12
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Healius AUD -19.2M 3M 2025-06
Integral Diagnostics AUD 14.49M 47.37M 2024-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Nanosonics AUD 11.39M 487K 2025-06
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06